← Eichor
Condition: Metastatic Gastrointestinal Stromal Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Metastatic Gastrointestinal Stromal Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Phase 2 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03977233A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · 54 location(s) · Bayer · NCT06760819Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Strom
Phase 2 · 1 location(s) · Jian Li · NCT07559864A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Expres
Phase 1 · 5 location(s) · Novelty Nobility, Inc. · NCT06805825KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Lin
Phase 2 · 16 location(s) · Kumquat Biosciences Inc. · NCT07406633Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment
Phase N/A · 1 location(s) · The Netherlands Cancer Institute · NCT07522762A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizu
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05152472Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (G
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05009927(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Phase 3 · 126 location(s) · Cogent Biosciences, Inc. · NCT05208047Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
Phase N/A · 1 location(s) · Xinhua Zhang, MD · NCT05461664Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments
Phase 1 · 2 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07618377A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
Phase N/A · 1 location(s) · Xinhua Zhang, MD · NCT05464875iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03608631Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatini
Phase 3 · 124 location(s) · GlaxoSmithKline · NCT07218926
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.